HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

DUALITYBIO-B

201.800

+0.2000.10%

Volume:715.52K

Turnover:144.98M

Market Cap:18.43B

PE:-4.34

High:208.000

Open:200.800

Low:198.600

Close:201.600

52wk High:376.800

52wk Low:158.500

Shares:91.31M

HK Float Shares:91.31M

Volume Ratio:1.21

T/O Rate:0.78%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-46.504

ROE:-65.93%

ROA:-24.30%

PB:10.87

PE(LYR):-4.34

PS:18.73

Loading ...

Overview Company News Filings

Duality Biotherapeutics Inc - Board Does not Recommend Payment of Interim Dividends

THOMSON REUTERS

Duality Biotherapeutics, Inc Hy Adjusted Loss Rmb626.9 Mln

THOMSON REUTERS

Duality Biotherapeutics FY26 H1 Loss Narrows to RMB 917.55 Million; Revenue Drops 82.16% to RMB 219.33 Million

Duality Biotherapeutics Ties Up With Genentech to Develop Oncology Drugs

MT Newswires Live

Duality Biotherapeutics Rises Most in Near Six Weeks on Roche's Genentech Tie-up

Dualitybio Enters a Global Collaboration and License Agreement with Genentech to Develop Next-Generation Adcs Built on Dualitybio's Dupac Novel-Payload Platform

THOMSON REUTERS

DUALITYBIO-B Surges Nearly 6% Following Genentech Licensing Pact

Movement Alert｜DUALITYBIO-B Rises 5.27% in Regular Trading, Signs Global ADC R&D Collaboration with Genentech Securing $45M Upfront Payment

Hong Kong Market Movers: Mixue's Revenue Reaches RMB 15.2 Billion in First Half, Global Store Network Expands

DUALITYBIO-B Inks Landmark Global ADC Collaboration with Roche's Genentech Using Proprietary DUPAC Platform

DualityBio Signs US$45.00 Million Upfront Collaboration With Genentech to Advance DUPAC-Based Next-Generation ADCs

Bulletin Express

Duality Biotherapeutics Inc - Global Research and Development Collaboration and License Agreement with Genentech

THOMSON REUTERS

Duality Biotherapeutics - Genentech to Obtain Exclusive Worldwide License to Collaboration Antibody-Drug Conjugates

THOMSON REUTERS

Duality Biotherapeutics - Dualitybio-B to Receive Upfront Payment of US$45 Mln Under Collaboration Agreement

THOMSON REUTERS

Duality Biotherapeutics Signs Genentech Pact for Next-Generation ADCs, Gets US$45 Million Upfront

HK Movers | Biotech Stocks Jump. CANSINOBIO Surges 17%; Innovent Bio up 11%; Akeso up over 8%; Everest Med up 7%

Tiger Newspress

Movement Alert｜DUALITYBIO-B Rises 5.12% in Regular Trading, Innovative Drug Sector Rally and Interim Results Approaching

Earning Preview: DUALITYBIO-B revenue outlook undisclosed and institutions tilt bullish

Movement Alert｜DUALITYBIO-B Rises 5.22% in Regular Trading, UBS Initiates Coverage with Buy Rating as Interim Results Approach

Movement Alert｜DUALITYBIO-B Rises 5.56% in Regular Trading, UBS Initiates Coverage with Buy Rating Amid Sector Strength

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/09606/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09606","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09606\",,,,,undefined,":{"symbol":"09606","market":"HK","secType":"STK","nameCN":"DUALITYBIO-B","latestPrice":201.8,"timestamp":1790755707008,"preClose":201.6,"halted":0,"volume":715517,"delay":0,"changeRate":0.0009920634920635766,"floatShares":91311400,"shares":91311400,"eps":-46.50385475430158,"marketStatus":"Not Yet Opened","change":0.2,"latestTime":"09-30 16:08:27","open":200.8,"high":208,"low":198.6,"amount":144976972,"amplitude":0.046627,"askPrice":201.8,"askSize":2200,"bidPrice":201.6,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-18.828381395643884,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790904600000},"marketStatusCode":0,"adr":0,"listingDate":1744646400000,"exchange":"SEHK","adjPreClose":201.6,"openAndCloseTimeList":[[1790731800000,1790740800000],[1790744400000,1790755200000]],"volumeRatio":1.2125976325299153,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09606\",,,,,undefined,":{"symbol":"09606","floatShares":91311400,"roa":"-24.30%","roe":"-65.93%","lyrEps":-46.503855,"volumeRatio":1.2125976325299153,"shares":91311400,"dividePrice":0,"high":208,"amplitude":0.046627,"preClose":201.6,"low":198.6,"week52Low":158.5,"pbRate":"10.87","psRate":"18.73","week52High":376.8,"institutionHeld":0,"latestPrice":201.8,"committee":-0.913043,"eps":-46.50385475430158,"divideRate":0,"volume":715517,"delay":0,"ttmEps":-18.828381395643884,"open":200.8,"prevYearClose":298.2,"prevWeekClose":196.8,"prevMonthClose":201.8,"prevQuarterClose":201.8,"fiveDayClose":215,"twentyDayClose":176,"sixtyDayClose":208},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09606\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"09606","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787880600000,"name":null,"time":"","dateTimestamp":1787846400000,"actualEps":null},{"date":"2026-03-23","symbol":"09606","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774229400000,"name":null,"time":"","dateTimestamp":1774195200000,"actualEps":null},{"date":"2025-08-26","symbol":"09606","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09606\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09606\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.5714,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":7,"updateTime":1786723200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09606\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09606","date":"2026-09-30","current":-10.717862,"percent":0.294444,"low":-29.984477,"twenty":-15.893657,"median":-9.404875,"eighty":-6.932282,"high":-4.703556,"avg":-11.503831,"sd":6.039483,"marketCap":18271822385},"quantilePoints":[{"date":"2025-04-17","current":-14.905978,"twenty":-15.065639,"median":-14.442293,"eighty":-11.334487,"marketCap":16635152800},{"date":"2025-04-25","current":-15.846935,"twenty":-16.770434,"median":-15.576033,"eighty":-14.349556,"marketCap":17719522633},{"date":"2025-05-02","current":-16.438538,"twenty":-16.715855,"median":-16.124153,"eighty":-14.985809,"marketCap":18420101638},{"date":"2025-05-09","current":-15.074661,"twenty":-16.551291,"median":-15.826729,"eighty":-15.074661,"marketCap":17010399982},{"date":"2025-05-16","current":-15.043786,"twenty":-16.438538,"median":-15.220044,"eighty":-14.405796,"marketCap":17114249721},{"date":"2025-05-23","current":-16.495727,"twenty":-16.438538,"median":-15.262587,"eighty":-14.582474,"marketCap":18822153243},{"date":"2025-05-30","current":-16.208434,"twenty":-16.401371,"median":-15.460562,"eighty":-14.726132,"marketCap":18575651704},{"date":"2025-06-06","current":-16.427701,"twenty":-16.438538,"median":-15.666395,"eighty":-14.905978,"marketCap":18874975001},{"date":"2025-06-13","current":-20.940103,"twenty":-16.693343,"median":-15.893657,"eighty":-15.005253,"marketCap":24069114577},{"date":"2025-06-20","current":-18.479443,"twenty":-18.428819,"median":-16.104695,"eighty":-15.043786,"marketCap":21199132371},{"date":"2025-06-27","current":-18.0452,"twenty":-18.863356,"median":-16.282988,"eighty":-15.074661,"marketCap":20758951051},{"date":"2025-07-04","current":-21.227749,"twenty":-18.942282,"median":-16.427701,"eighty":-15.074735,"marketCap":24421259633},{"date":"2025-07-11","current":-22.045806,"twenty":-19.683704,"median":-16.508309,"eighty":-15.190609,"marketCap":25336836779},{"date":"2025-07-18","current":-25.758166,"twenty":-20.839221,"median":-16.693343,"eighty":-15.21995,"marketCap":29580184704},{"date":"2025-07-25","current":-25.970367,"twenty":-21.539184,"median":-16.981252,"eighty":-15.260218,"marketCap":29932329760},{"date":"2025-08-01","current":-24.963588,"twenty":-22.267132,"median":-18.096065,"eighty":-15.298157,"marketCap":28594178547},{"date":"2025-08-08","current":-27.998627,"twenty":-24.402884,"median":-18.454131,"eighty":-15.429476,"marketCap":32150843612},{"date":"2025-08-15","current":-27.487815,"twenty":-25.397092,"median":-18.863356,"eighty":-15.513126,"marketCap":31516982512},{"date":"2025-08-22","current":-26.341915,"twenty":-25.761111,"median":-19.052333,"eighty":-15.750472,"marketCap":30108402288},{"date":"2025-08-29","current":-8.977182,"twenty":-25.761111,"median":-19.118727,"eighty":-15.513126,"marketCap":27784244918},{"date":"2025-09-05","current":-10.341403,"twenty":-25.547361,"median":-18.897362,"eighty":-15.21995,"marketCap":31974771084},{"date":"2025-09-12","current":-12.806892,"twenty":-25.484142,"median":-18.479443,"eighty":-15.036079,"marketCap":39669140558},{"date":"2025-09-19","current":-11.291493,"twenty":-25.397092,"median":-18.151913,"eighty":-14.569138,"marketCap":34950396808},{"date":"2025-09-26","current":-9.575685,"twenty":-25.265241,"median":-17.183112,"eighty":-14.242848,"marketCap":29562577451},{"date":"2025-10-03","current":-9.769092,"twenty":-25.225948,"median":-16.756996,"eighty":-13.467837,"marketCap":30231653057},{"date":"2025-10-10","current":-8.39875,"twenty":-25.201143,"median":-16.551291,"eighty":-12.508489,"marketCap":25953090627},{"date":"2025-10-17","current":-9.52866,"twenty":-25.090759,"median":-16.467132,"eighty":-11.127698,"marketCap":29421719428},{"date":"2025-10-24","current":-8.24833,"twenty":-24.683236,"median":-16.401371,"eighty":-10.383008,"marketCap":25477694801},{"date":"2025-10-31","current":-8.936138,"twenty":-24.228898,"median":-16.208434,"eighty":-10.01166,"marketCap":27643386896},{"date":"2025-11-07","current":-8.115895,"twenty":-24.0933,"median":-15.983588,"eighty":-9.661913,"marketCap":25090335240},{"date":"2025-11-14","current":-9.615008,"twenty":-24.036348,"median":-15.846935,"eighty":-9.533336,"marketCap":29809078990},{"date":"2025-11-21","current":-8.88084,"twenty":-23.659864,"median":-15.493415,"eighty":-9.411746,"marketCap":27520136126},{"date":"2025-11-28","current":-9.805814,"twenty":-23.032171,"median":-15.270261,"eighty":-9.358381,"marketCap":30496838785},{"date":"2025-12-05","current":-9.522579,"twenty":-22.810207,"median":-15.147164,"eighty":-9.358381,"marketCap":29666872704},{"date":"2025-12-12","current":-9.227769,"twenty":-22.078047,"median":-15.043786,"eighty":-9.232281,"marketCap":28801588916},{"date":"2025-12-19","current":-9.562517,"twenty":-22.024358,"median":-14.816055,"eighty":-9.195431,"marketCap":29916743432},{"date":"2025-12-24","current":-8.86445,"twenty":-21.960012,"median":-14.582474,"eighty":-9.185632,"marketCap":27819193982},{"date":"2026-01-02","current":-8.361415,"twenty":-21.780535,"median":-14.405796,"eighty":-9.071858,"marketCap":26343799029},{"date":"2026-01-09","current":-10.158481,"twenty":-21.573184,"median":-14.143758,"eighty":-9.138635,"marketCap":32085396254},{"date":"2026-01-16","current":-10.130227,"twenty":-21.338723,"median":-13.671075,"eighty":-9.159542,"marketCap":32100133626},{"date":"2026-01-23","current":-9.450777,"twenty":-21.128733,"median":-12.833558,"eighty":-9.159542,"marketCap":29918397524},{"date":"2026-01-30","current":-9.27281,"twenty":-20.989151,"median":-11.556174,"eighty":-9.159542,"marketCap":29489203537},{"date":"2026-02-06","current":-8.834279,"twenty":-20.864442,"median":-11.154997,"eighty":-9.026205,"marketCap":28165855410},{"date":"2026-02-13","current":-9.445101,"twenty":-20.730279,"median":-10.443288,"eighty":-9.076015,"marketCap":30286271904},{"date":"2026-02-20","current":-9.824687,"twenty":-20.674464,"median":-10.43817,"eighty":-9.09489,"marketCap":31458062186},{"date":"2026-02-27","current":-8.771359,"twenty":-20.006759,"median":-10.305855,"eighty":-9.047703,"marketCap":28393379910},{"date":"2026-03-06","current":-8.859488,"twenty":-19.896232,"median":-10.18539,"eighty":-8.969972,"marketCap":28447462538},{"date":"2026-03-13","current":-7.555838,"twenty":-19.630572,"median":-10.144354,"eighty":-8.935093,"marketCap":24373237865},{"date":"2026-03-20","current":-7.859442,"twenty":-19.432697,"median":-9.991099,"eighty":-8.867218,"marketCap":25256587462},{"date":"2026-03-27","current":-8.718949,"twenty":-19.118727,"median":-9.951719,"eighty":-8.854358,"marketCap":25617138318},{"date":"2026-04-02","current":-9.880216,"twenty":-19.012497,"median":-9.885599,"eighty":-8.850342,"marketCap":29168564250},{"date":"2026-04-10","current":-9.180446,"twenty":-18.964111,"median":-9.878849,"eighty":-8.85641,"marketCap":27311727342},{"date":"2026-04-17","current":-9.417233,"twenty":-18.904163,"median":-9.820225,"eighty":-8.842311,"marketCap":28027927148},{"date":"2026-04-24","current":-8.878352,"twenty":-18.860571,"median":-9.805814,"eighty":-8.846908,"marketCap":26425587896},{"date":"2026-04-30","current":-8.372511,"twenty":-18.781003,"median":-9.783435,"eighty":-8.82699,"marketCap":24926391864},{"date":"2026-05-08","current":-7.738947,"twenty":-18.469318,"median":-9.736996,"eighty":-8.785939,"marketCap":23120131584},{"date":"2026-05-15","current":-6.609967,"twenty":-18.384608,"median":-9.691452,"eighty":-8.751075,"marketCap":20699742808},{"date":"2026-05-22","current":-6.440114,"twenty":-18.185423,"median":-9.652725,"eighty":-8.708072,"marketCap":20121739519},{"date":"2026-05-29","current":-6.506712,"twenty":-18.096065,"median":-9.620334,"eighty":-8.669056,"marketCap":20400514838},{"date":"2026-06-05","current":-5.374082,"twenty":-18.0452,"median":-9.575685,"eighty":-8.511806,"marketCap":16873830092},{"date":"2026-06-12","current":-5.36331,"twenty":-17.183112,"median":-9.557279,"eighty":-8.481744,"marketCap":16828616185},{"date":"2026-06-18","current":-5.321722,"twenty":-16.860136,"median":-9.537613,"eighty":-8.412993,"marketCap":16738188371},{"date":"2026-06-26","current":-4.703556,"twenty":-16.761475,"median":-9.522579,"eighty":-8.375473,"marketCap":14721648119},{"date":"2026-07-03","current":-6.212828,"twenty":-16.718804,"median":-9.508222,"eighty":-8.310046,"marketCap":19460065572},{"date":"2026-07-10","current":-6.457487,"twenty":-16.608112,"median":-9.462457,"eighty":-8.218812,"marketCap":20201573647},{"date":"2026-07-17","current":-6.192643,"twenty":-16.533051,"median":-9.445101,"eighty":-8.097368,"marketCap":19441980010},{"date":"2026-07-24","current":-6.744145,"twenty":-16.505793,"median":-9.428231,"eighty":-7.995787,"marketCap":21178194038},{"date":"2026-07-31","current":-5.225281,"twenty":-16.472851,"median":-9.409879,"eighty":-7.856069,"marketCap":16439776585},{"date":"2026-08-07","current":-5.555188,"twenty":-16.434203,"median":-9.398864,"eighty":-7.73561,"marketCap":17511664790},{"date":"2026-08-14","current":-5.519506,"twenty":-16.417169,"median":-9.342917,"eighty":-7.473767,"marketCap":17421211976},{"date":"2026-08-21","current":-5.561665,"twenty":-16.354018,"median":-9.310353,"eighty":-6.918832,"marketCap":17593072323},{"date":"2026-08-28","current":-5.723357,"twenty":-16.253166,"median":-9.270261,"eighty":-6.767757,"marketCap":18108653362},{"date":"2026-09-04","current":-9.738306,"twenty":-16.191745,"median":-9.310353,"eighty":-6.781144,"marketCap":16344823489},{"date":"2026-09-11","current":-9.079348,"twenty":-16.117099,"median":-9.324437,"eighty":-6.805148,"marketCap":15259389721},{"date":"2026-09-18","current":-10.61548,"twenty":-15.995407,"median":-9.346758,"eighty":-6.863392,"marketCap":17864430765},{"date":"2026-09-25","current":-10.598054,"twenty":-15.912162,"median":-9.401339,"eighty":-6.918832,"marketCap":17801113795},{"date":"2026-09-30","current":-10.858508,"twenty":-15.893657,"median":-9.404875,"eighty":-6.932282,"marketCap":18271822385}],"updateTime":1790895204406},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09606\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662018061","title":"Duality Biotherapeutics Inc - Board Does not Recommend Payment of Interim Dividends","url":"https://stock-news.laohu8.com/highlight/detail?id=2662018061","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662018061?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:35","pubTimestamp":1787913328,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nFWN44P10A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2543165471.USD","BK1161","HK0000500386.USD","09606","HK0000252152.HKD","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662061058","title":"Duality Biotherapeutics, Inc Hy Adjusted Loss Rmb626.9 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662061058","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662061058?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:34","pubTimestamp":1787913284,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nPLXR1NRTL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["09606","LU2543165471.USD","HK0000252152.HKD","HK0000500386.USD","HK0000252160.HKD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662061057","title":"Duality Biotherapeutics FY26 H1 Loss Narrows to RMB 917.55 Million; Revenue Drops 82.16% to RMB 219.33 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662061057","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662061057?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:34","pubTimestamp":1787913245,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics FY26 H1 loss narrows to RMB 917.55 million; revenue drops 82.16% to RMB 219.33 millionDuality Biotherapeutics posted revenue of RMB 219.33 million for the six months ended June","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL2TQR06:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606","BK1161","HK0000500386.USD","HK0000252160.HKD","LU2543165471.USD","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662685460","title":"Duality Biotherapeutics Ties Up With Genentech to Develop Oncology Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2662685460","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662685460?lang=en_us&edition=fundamental","pubTime":"2026-08-28 16:46","pubTimestamp":1787906779,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics  partnered with Roche Group's Genentech to develop oncology drugs based on the DualityBio Unique Payload Antibody Conjugate platform, according to a Friday disclosure on the Hong Kong bourse.The Hong Kong-listed biotherapy company will receive an upfront payment of $45 million as part of the deal, as well as milestone payments of over $1 billion.Duality will also receive tiered royalty payments on annual net sales of products approved from the partnership.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","09606","HK0000500386.USD","LU2543165471.USD","HK0000252152.HKD","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662056343","title":"Duality Biotherapeutics Rises Most in Near Six Weeks on Roche's Genentech Tie-up","url":"https://stock-news.laohu8.com/highlight/detail?id=2662056343","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662056343?lang=en_us&edition=fundamental","pubTime":"2026-08-28 12:53","pubTimestamp":1787892800,"startTime":"0","endTime":"0","summary":"BUZZ-Duality Biotherapeutics rises most in near six weeks on Roche's Genentech tie-up** Shares of Duality Biotherapeutics Inc9606.HKrise 6.3% to HK$207.8, on track for biggest one-day pctadvancesince July 20** Stock hit the highest level since August 11** Duality said it entered into a collaboration and license agreement with Roche Group's Genentech Inc to develop next-generation antibody-drug conjugates  targeting certain oncology indications** Duality will lead discovery and early global clinical development while Genentech will obtain an exclusive worldwide license to the resulting collaboration ADCs** Duality will receive an upfront payment of $45 million and will be eligible to receive potential development, regulatory and commercial milestone payments ofmore than $1 billionacross all collaboration programs** HK-listed company says it will be entitled to receive tiered royalty payments on annual net sales of approved products arising from the collaboration** YTD, stock down 30.7%,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL4N44P07N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","HK0000500386.USD","LU2543165471.USD","HK0000252152.HKD","HK0000252160.HKD","09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662314055","title":"Dualitybio Enters a Global Collaboration and License Agreement with Genentech to Develop Next-Generation Adcs Built on Dualitybio's Dupac Novel-Payload Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2662314055","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662314055?lang=en_us&edition=fundamental","pubTime":"2026-08-28 12:09","pubTimestamp":1787890143,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nTUA6KBFRC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000500386.USD","LU2543165471.USD","HK0000252152.HKD","HK0000252160.HKD","09606","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106015884","title":"DUALITYBIO-B Surges Nearly 6% Following Genentech Licensing Pact","url":"https://stock-news.laohu8.com/highlight/detail?id=1106015884","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106015884?lang=en_us&edition=fundamental","pubTime":"2026-08-28 11:51","pubTimestamp":1787889103,"startTime":"0","endTime":"0","summary":"DUALITYBIO-B (09606) saw its share price climb nearly 6% during the morning trading session. As of the latest update, the stock was up 5.78% at HK$206.80, with trading turnover reaching HK$108...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606","LU2543165471.USD","HK0000252152.HKD","HK0000500386.USD","HK0000252160.HKD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166382217","title":"Movement Alert｜DUALITYBIO-B Rises 5.27% in Regular Trading, Signs Global ADC R&D Collaboration with Genentech Securing $45M Upfront Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=1166382217","media":"Market Focus","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166382217?lang=en_us&edition=fundamental","pubTime":"2026-08-28 09:34","pubTimestamp":1787880889,"startTime":"0","endTime":"0","summary":"On August 28, DUALITYBIO-B rose 5.27% in regular trading, trading at 204.0 HKD/share, with turnover of approximately 28.91 million HKD. The rally was driven by the announcement of a global research,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"DUALITYBIO-B Gains on $45M Genentech ADC Deal and UBS Buy","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108068616","title":"Hong Kong Market Movers: Mixue's Revenue Reaches RMB 15.2 Billion in First Half, Global Store Network Expands","url":"https://stock-news.laohu8.com/highlight/detail?id=1108068616","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108068616?lang=en_us&edition=fundamental","pubTime":"2026-08-28 09:12","pubTimestamp":1787879553,"startTime":"0","endTime":"0","summary":"HUTCHMED (00013) has received approval from China's National Medical Products Administration for Elenestinib (futibatinib) to treat patients with FGFR2 fusion/rearrangement intrahepatic...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1219","02273","BK1587","BK1616","BK1161","02097","BK4588","KCAI","LU2543165471.USD","09606","HK0000252152.HKD","BK1191","BK1233","HK0000252160.HKD","VXUS","HK0000500386.USD","BK1588","LU2460026573.USD","02005","BK4585","00013"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111197255","title":"DUALITYBIO-B Inks Landmark Global ADC Collaboration with Roche's Genentech Using Proprietary DUPAC Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=1111197255","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111197255?lang=en_us&edition=fundamental","pubTime":"2026-08-28 08:02","pubTimestamp":1787875336,"startTime":"0","endTime":"0","summary":"DUALITYBIO-B (09606) has announced the signing of a collaboration and license agreement with Genentech, Inc., a member of the Roche Group, dated August 27, 2026. The partnership leverages...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","HK0000252152.HKD","HK0000252160.HKD","LU2543165471.USD","09606","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164922970","title":"DualityBio Signs US$45.00 Million Upfront Collaboration With Genentech to Advance DUPAC-Based Next-Generation ADCs","url":"https://stock-news.laohu8.com/highlight/detail?id=1164922970","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164922970?lang=en_us&edition=fundamental","pubTime":"2026-08-28 07:41","pubTimestamp":1787874103,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics, Inc. (DualityBio) has entered into a global research, development and license agreement with Genentech, Inc., a member of the Roche Group, aimed at creating next-generation...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662547031","title":"Duality Biotherapeutics Inc - Global Research and Development Collaboration and License Agreement with Genentech","url":"https://stock-news.laohu8.com/highlight/detail?id=2662547031","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662547031?lang=en_us&edition=fundamental","pubTime":"2026-08-28 07:19","pubTimestamp":1787872762,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O1MV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["09606","BK1161","HK0000500386.USD","HK0000252160.HKD","LU2543165471.USD","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662315440","title":"Duality Biotherapeutics - Genentech to Obtain Exclusive Worldwide License to Collaboration Antibody-Drug Conjugates","url":"https://stock-news.laohu8.com/highlight/detail?id=2662315440","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662315440?lang=en_us&edition=fundamental","pubTime":"2026-08-28 07:19","pubTimestamp":1787872762,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O1MV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","LU2543165471.USD","HK0000252160.HKD","HK0000252152.HKD","HK0000500386.USD","09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662103166","title":"Duality Biotherapeutics - Dualitybio-B to Receive Upfront Payment of US$45 Mln Under Collaboration Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2662103166","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662103166?lang=en_us&edition=fundamental","pubTime":"2026-08-28 07:19","pubTimestamp":1787872762,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O1MV:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000500386.USD","LU2543165471.USD","BK1161","HK0000252152.HKD","09606","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662523031","title":"Duality Biotherapeutics Signs Genentech Pact for Next-Generation ADCs, Gets US$45 Million Upfront","url":"https://stock-news.laohu8.com/highlight/detail?id=2662523031","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662523031?lang=en_us&edition=fundamental","pubTime":"2026-08-28 07:19","pubTimestamp":1787872752,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics signs Genentech pact for next-generation ADCs, gets US$45 million upfrontDuality Biotherapeutics entered a global R&D collaboration with Roche unit Genentech on Aug. 27, 2026 t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL1FV5nS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","HK0000252152.HKD","09606","HK0000252160.HKD","LU2543165471.USD","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136334991","title":"HK Movers | Biotech Stocks Jump. CANSINOBIO Surges 17%; Innovent Bio up 11%; Akeso up over 8%; Everest Med up 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1136334991","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136334991?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:47","pubTimestamp":1787708820,"startTime":"0","endTime":"0","summary":"Biotech stocks jumped in Hong Kong market. CANSINOBIO surged 17%; Innovent Bio up 11%; Akeso up over 8%; Everest Med up 7%.On the news front, $CANSINOBIO(06185)$ announced on August 25 that its...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966","09688","06606","01672","02359","02137","09995","02269","06978","09606","03759","03347","02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186876654","title":"Movement Alert｜DUALITYBIO-B Rises 5.12% in Regular Trading, Innovative Drug Sector Rally and Interim Results Approaching","url":"https://stock-news.laohu8.com/highlight/detail?id=1186876654","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186876654?lang=en_us&edition=fundamental","pubTime":"2026-08-25 10:12","pubTimestamp":1787623940,"startTime":"0","endTime":"0","summary":"On August 25, DUALITYBIO-B rose 5.12% in regular trading, trading at HK$199.8/share, with turnover of HK$27.67 million.On the news front, the Hong Kong-listed innovative drug sector was broadly...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"UBS Initiates Buy on DUALITYBIO-B as Stock Rises","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124763100","title":"Earning Preview: DUALITYBIO-B revenue outlook undisclosed and institutions tilt bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1124763100","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124763100?lang=en_us&edition=fundamental","pubTime":"2026-08-21 14:36","pubTimestamp":1787294217,"startTime":"0","endTime":"0","summary":"Abstract Duality Biotherapeutics-B will release interim financial results on August 28, 2026 post-Market; this preview summarizes the latest quarterly performance, updates available forecasts, and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: DUALITYBIO-B revenue outlook undisclosed and institutions tilt bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103697001","title":"Movement Alert｜DUALITYBIO-B Rises 5.22% in Regular Trading, UBS Initiates Coverage with Buy Rating as Interim Results Approach","url":"https://stock-news.laohu8.com/highlight/detail?id=1103697001","media":"Market Focus","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103697001?lang=en_us&edition=fundamental","pubTime":"2026-08-21 10:38","pubTimestamp":1787279913,"startTime":"0","endTime":"0","summary":"On August 21, DUALITYBIO-B rose 5.22% in regular trading, trading at HKD 197.5/share, with turnover of HKD 48.06 million.On the news front, UBS recently initiated coverage on DUALITYBIO-B with a Buy...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"UBS Initiates Buy on DUALITYBIO-B, Stock Rises","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163972513","title":"Movement Alert｜DUALITYBIO-B Rises 5.56% in Regular Trading, UBS Initiates Coverage with Buy Rating Amid Sector Strength","url":"https://stock-news.laohu8.com/highlight/detail?id=1163972513","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163972513?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:44","pubTimestamp":1787190274,"startTime":"0","endTime":"0","summary":"On August 20, DUALITYBIO-B rose 5.56% in regular trading, trading at 195.4 HKD/share, with turnover of approximately 42.40 million HKD. The rally was driven by UBS initiating coverage with a \\\"Buy\\\"...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"DUALITYBIO-B Rises as UBS Initiates Coverage with Buy Rating Amid Sector Strength","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":2,"totalSize":144,"code":"91000000","status":"200"}]}}